Equity Awards and Warrants - Private Placement of Shares of Common Stock and Warrants (Details)
   | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
1 Months Ended | 
3 Months Ended | 
9 Months Ended | 
12 Months Ended | 
 | 
 | 
 | 
 | 
 | 
| 
 Feb. 13, 2023  
USD ($)  
$ / shares  
shares 
 | 
 Jan. 12, 2023  
$ / shares 
 | 
 Aug. 31, 2022  
USD ($)  
$ / shares  
shares 
 | 
 Aug. 30, 2022  
$ / shares  
shares 
 | 
 Aug. 02, 2022  
shares 
 | 
 Mar. 25, 2022  
shares 
 | 
 Feb. 14, 2022  
shares 
 | 
 Feb. 04, 2022  
shares 
 | 
 May 31, 2021  
USD ($)  
$ / shares  
shares 
 | 
 Mar. 31, 2023  
USD ($)  
$ / shares  
shares 
 | 
 Jan. 31, 2023  
USD ($)  
$ / shares  
shares 
 | 
 Nov. 30, 2022  
USD ($)  
$ / shares  
shares 
 | 
 Jul. 31, 2022  
shares 
 | 
 Jun. 30, 2022  
USD ($)  
$ / shares  
shares 
 | 
 Apr. 30, 2022  
shares 
 | 
 Feb. 28, 2022  
USD ($)  
$ / shares  
shares 
 | 
 Mar. 31, 2023  
USD ($)  
$ / shares  
shares 
 | 
 Feb. 28, 2023  
USD ($)  
$ / shares  
shares 
 | 
 Aug. 31, 2022  
USD ($)  
$ / shares  
shares 
 | 
 Jun. 30, 2022  
USD ($)  
$ / shares  
shares 
 | 
 Feb. 28, 2022  
USD ($)  
$ / shares  
shares 
 | 
 Nov. 30, 2021  
USD ($) 
 | 
[1] | 
 Aug. 31, 2021  
USD ($) 
 | 
[1] | 
 Feb. 28, 2023  
USD ($)  
$ / shares  
shares 
 | 
 Feb. 28, 2022  
USD ($)  
$ / shares  
shares 
 | 
 May 31, 2022  
USD ($)  
item  
$ / shares  
shares 
 | 
 May 31, 2021  
USD ($)  
$ / shares  
shares 
 | 
 Mar. 10, 2023  
USD ($) 
 | 
 Jan. 05, 2023  
USD ($) 
 | 
 Dec. 31, 2022  
$ / shares  
shares 
 | 
 Jul. 08, 2022  
shares 
 | 
 Jul. 07, 2022  
shares 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.50
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.50
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Warrant exercises (in shares) | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
1,400,000
 | 
26,700,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise of warrants for cash | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
$ 300,000
 | 
 
 | 
 | 
$ 1,000,000.0
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise of warrants for cash, shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
500,000
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Cashless exercise of warrants, shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
200,000
 | 
 
 | 
 | 
200,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Cashless exercise of warrants, warrants | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
300,000
 | 
 
 | 
 | 
300,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued during the period new issues shares | 
400,000
 | 
 
 | 
4,600,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
500,000
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
7,900,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Finance charges related to warrant issuance for surety bond backstop agreement | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 4,885,000
 | 
$ 8,601,000
 | 
 
 | 
$ 6,585,000
 | 
[1] | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 6,585,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Common stock warrants to purchase shares | 
 
 | 
 
 | 
5,500,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
71,100,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
71,100,000
 | 
 
 | 
5,500,000
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Term of warrants | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
5 years
 | 
10 years
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
5 years
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Number Of Warrants In fixed Combination Issue Of Securities | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
0.3
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Warrant covering common stock shares purchased, percentage | 
 
 | 
 
 | 
75.00%
 | 
50.00%
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
12.00%
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Placement agent fees and expenses | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 2,000,000.0
 | 
 
 | 
 
 | 
$ 2,800,000
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Stock issued for private offerings | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
18,045,000
 | 
 
 | 
 
 | 
$ 3,552,000
 | 
[1] | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 46,511,000
 | 
$ 1,000,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Incremental fair value of warrants | $ | 
 
 | 
 
 | 
$ 4,200,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 100,000
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Number of warrants expiration extended | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
3,800,000
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Proceeds from warrant exercises | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
$ 264,000
 | 
$ 1,036,000
 | 
[1] | 
$ 1,036,000
 | 
$ 19,428,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Deemed dividends | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
$ 500,000
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Common Stock, Shares Authorized | 
 
 | 
 
 | 
1,350,000,000
 | 
1,000,000,000.0
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1,350,000,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1,350,000,000
 | 
1,350,000,000
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
1,350,000,000
 | 
 
 | 
 | 
1,350,000,000
 | 
1,350,000,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| CytoDyn Inc. | David F Welch | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Ownership percentage | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
5.00%
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
5.00%
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Back Stop Warrant #1 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.10
 | 
 
 | 
 
 | 
| Common stock warrants to purchase shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
7,500,000
 | 
 
 | 
 
 | 
| Back Stop Warrant #2 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.10
 | 
 
 | 
 
 | 
| Common stock warrants to purchase shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
7,500,000
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
7,500,000
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
7,500,000
 | 
 
 | 
 
 | 
| Former CEO | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Compensation policy period | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
18 months
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued during the period new issues shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
908,418
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
380,704
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Former General Counsel | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Compensation policy period | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
12 months
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Severance payment | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 12,500
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued during the period new issues shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
79,391
 | 
 
 | 
 | 
155,612
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Executives | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Percent of salary in lieu of cash, net of payroll deductions and withholding taxes | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
25.00%
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
522,382
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
317,441
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Private Equity Offering | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued during the period new issues shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
8,900,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Stock based compensation | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 14,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Term of warrants | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
5 years
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
5 years
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Number of common shares in a fixed combination issue of shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Number Of Warrants In fixed Combination Issue Of Securities | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Stock issued for private offerings | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 17,544,000
 | 
 
 | 
 
 | 
 | 
$ 27,307,000
 | 
$ 2,872,000
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Proceeds from warrant exercises | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
$ 23,600,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Private Equity Offering | Consultant | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 1.04
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 1.04
 | 
 | 
 
 | 
 
 | 
 
 | 
$ 1.04
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued during the period new issues shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
15,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Common stock warrants to purchase shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
25,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
25,000
 | 
 | 
 
 | 
 
 | 
 
 | 
25,000
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Private Equity Offering | Placement Agent | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 0.40
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Warrant exercises (in shares) | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
11,400,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued during the period new issues shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
38,100,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Common stock warrants to purchase shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
1,600,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Term of warrants | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
7 years
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Non-cash inducement interest expense | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 1,700,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Cash inducement interest expense | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 200,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Accredited Investors | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Warrant exercises (in shares) | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
2,300,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued during the period new issues shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
4,100,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
85,400,000
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
34,600,000
 | 
8,800,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Common stock warrants to purchase shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
900,000
 | 
71.1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
71.1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
900,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Non-cash inducement interest expense | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 5,200,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Stock issued for private offerings | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 14,400,000
 | 
 
 | 
 
 | 
$ 18,900,000
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 5,400,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Proceeds, net of issuance costs | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 13,300,000
 | 
 
 | 
 
 | 
$ 7,700,000
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Private Warrant Exchange [Member] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 1.00
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Warrants exchanged (in shares) | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
3,500,000
 | 
32,600,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued during the period new issues shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
36,200,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
35,800,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Common stock warrants to purchase shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
7,900,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Non-cash inducement interest expense | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
$ 14,000,000.0
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Placement agent fees and expenses | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 2,100,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
500,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Stock issued for private offerings | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 34,900,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise of warrants, net of offering costs (in shares) | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
9,700,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued on warrant inducement | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
8,400,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Proceeds from warrant exercises | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 2,100,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Deemed dividends | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 500,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Private Warrant Exchange [Member] | Cyrus Arman | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
$ 0.50
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued during the period new issues shares | 
400,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Common stock warrants to purchase shares | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Number of shares per warrant | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Proceeds from Issuance of Common Stock | $ | 
$ 100,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Number of shares per unit | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Private Warrant Exchange [Member] | Placement Agent | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Non-cash inducement interest expense | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 6,700,000
 | 
$ 13,900,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Private Warrant Exchange, Non-Inducement Shares [Member] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued during the period new issues shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
400,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Non-cash inducement interest expense | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 1,500,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Allotment to placement agent | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
$ 0.40
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.23
 | 
 
 | 
 
 | 
$ 0.255
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.255
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 0.255
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Increase in number of shares authorized | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
350,000,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Common stock warrants to purchase shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
10,700,000
 | 
 
 | 
 
 | 
19,400,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
19,400,000
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Term of warrants | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
10 years
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
10 years
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
10 years
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Warrant covering common stock shares purchased, percentage | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
15.00%
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
12.00%
 | 
 
 | 
 
 | 
13.00%
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
13.00%
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Placement agent fees and expenses | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 25,000
 | 
 
 | 
 
 | 
$ 50,000
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 50,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Allotment to placement agent | Placement Agent | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 1.00
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued during the period new issues shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
1,400,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Term of warrants | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
10 years
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Warrant covering common stock shares purchased, percentage | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
12.00%
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Second Private Placement | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.306
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.306
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 0.30
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of stock warrant combo, per share | $ / shares | 
 
 | 
$ 0.23
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.255
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.255
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 0.255
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued during the period new issues shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
65.6
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
34,600,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Common stock warrants to purchase shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
64,000,000.0
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
64,000,000.0
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Term of warrants | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
5 years
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
5 years
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
5 years
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Number of common shares in a fixed combination issue of shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1
 | 
 
 | 
 
 | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Number Of Warrants In fixed Combination Issue Of Securities | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1
 | 
 
 | 
 
 | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Warrant exercise price percentage of final unit price | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
120.00%
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
120.00%
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Proceeds from warrant exercises | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 8,800,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Closing share price (as percentage) | 
 
 | 
90.00%
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Stock Subscription Agreements [Member] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 1.00
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Number of private placements conducted | item | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
2
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued during the period new issues shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
11,400,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Common stock warrants to purchase shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
5,000,000.0
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Number of common shares in a fixed combination issue of shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Placement agent fees and expenses | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 50,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Proceeds from Issuance of Common Stock | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
11,400,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Stock issued for private offerings | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
10,000,000.0
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Surety Bond Backstop Agreement | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Stock based compensation | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 6,600,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Finance charges related to warrant issuance for surety bond backstop agreement | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
$ 4,900,000
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Common stock warrants to purchase shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
15,000,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Interest rate | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
10.00%
 | 
10.00%
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Period of Indemnification, Payment by Indemnitors | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
90 days
 | 
90 days
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Indemnification Fee Payment Ratio | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1.50%
 | 
1.50%
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Amount of cash collateral to be relieved of amount currently pledged | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 5,100,000
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
5,100,000
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Amount of cash collateral to be relieved of amount currently pledged by Indemnity in support of Surety Bond | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 5,000,000.0
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Restricted Cash | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 5,100,000
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
$ 5,100,000
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Surety Bond Backstop Agreement | Four Good Warrants | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.10
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
$ 0.10
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Term of warrants | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
5 years
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
5 years
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Initial Warrant | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Common stock warrants to purchase shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
15,000,000.0
 | 
15,000,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Make-Whole Warrant | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Common stock warrants to purchase shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
15,000,000.0
 | 
15,000,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Four Good Warrants | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 0.20
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Finance charges related to warrant issuance for surety bond backstop agreement | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 6,600,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Term of warrants | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
5 years
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Warrant Exchange Agreements [Member] | Accredited Investors Warrants [Member] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Warrant exercises (in shares) | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
3,400,000
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued on warrant inducement | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
600,000
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Proceeds from warrant exercises | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 700,000
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Restricted Cash | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 100,000
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
$ 100,000
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Maximum | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
$ 0.255
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 1.00
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.75
 | 
$ 0.255
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
$ 0.75
 | 
 
 | 
 | 
$ 1.35
 | 
$ 1.00
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Cashless exercise of warrants, exercise price | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
0.50
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
0.50
 | 
 
 | 
 | 
0.83
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Maximum | Private Equity Offering | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1.80
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
1.80
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Maximum | Accredited Investors | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1.00
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
1.00
 | 
1.00
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Maximum | Private Warrant Exchange [Member] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
0.90
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
0.90
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Warrants grant date fair value | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1.50
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
1.50
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Maximum | Allotment to placement agent | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
$ 0.306
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.306
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Maximum | Four Good Warrants | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
0.30
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Maximum | Warrant Exchange Agreements [Member] | Accredited Investors Warrants [Member] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
0.75
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
0.75
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Minimum | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
0.45
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
0.45
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
0.45
 | 
 
 | 
 | 
0.45
 | 
0.45
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Cashless exercise of warrants, exercise price | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
0.26
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
0.26
 | 
 
 | 
 | 
0.40
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Warrant covering common stock shares purchased, percentage | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
0.40%
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Minimum | Private Equity Offering | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
0.40
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
0.40
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Minimum | Accredited Investors | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
0.40
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 0.45
 | 
0.40
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Minimum | Private Warrant Exchange [Member] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
0.21
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
0.21
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Warrants grant date fair value | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.30
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
$ 0.30
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Minimum | Surety Bond Backstop Agreement | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Amount of cash collateral to be relieved of amount currently pledged | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
$ 1,500,000
 | 
 
 | 
 
 | 
 
 | 
| Minimum | Warrant Exchange Agreements [Member] | Accredited Investors Warrants [Member] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.50
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
$ 0.50
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Subsequent Event | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Stock issued for private offerings | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 1,100,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Common Stock, Shares Authorized | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1,350,000,000
 | 
1,000,000,000
 | 
| Subsequent Event | Former CEO | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued during the period new issues shares | 
 
 | 
 
 | 
 
 | 
 
 | 
69,040
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
26,106
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Subsequent Event | Private Equity Offering | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.30
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.30
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of stock warrant combo, per share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.255
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.255
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Shares issued during the period new issues shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
50,700,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Number of shares per warrant | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
0.75
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
0.75
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Term of warrants | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
5 years
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
5 years
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Warrant exercise price percentage of final unit price | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
120.00%
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Proceeds, net of issuance costs | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 11,300,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Subsequent Event | Private Equity Offering | Placement Agent | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Exercise price of share | $ / shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.50
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 0.50
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Common stock warrants to purchase shares | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
5,500,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
5,500,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Number of shares per warrant | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Term of warrants | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
5 years
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
5 years
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Proceeds, net of issuance costs | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
$ 1,100,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Number of shares per unit | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
1
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Subsequent Event | Surety Bond Backstop Agreement | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| Amount of cash collateral to be relieved of amount currently pledged | $ | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 
 | 
$ 1,400,000
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 |